Literature DB >> 28400243

Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.

Constantinos P Zambirinis1, George Miller2.   

Abstract

Homeostasis is a fundamental property of living organisms enabling the human body to withstand internal and external insults. In several chronic diseases, and especially in cancer, many homeostatic mechanisms are deranged. Pancreatic cancer in particular is notorious for its ability to invoke an intense fibroinflammatory stromal reaction facilitating its progression and resistance to treatment. In the past decade, several seminal discoveries have elucidated previously unrecognized modes of commandeering the host's defense systems. Here we review novel discoveries in pancreatic cancer immunobiology and attempt to integrate the notion of deranged homeostasis in the pathogenesis of this disease. We also highlight areas of controversy and obstacles that need to be overcome, hoping to further our mechanistic insight into this malignancy. Published by Elsevier Ltd.

Entities:  

Keywords:  cancer-associated fibroblasts; immunity; inflammation; pancreatic ductal adenocarcinoma; stroma

Mesh:

Year:  2017        PMID: 28400243      PMCID: PMC5480288          DOI: 10.1016/j.molmed.2017.03.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  110 in total

1.  CD4(+ )T cells play an important role in acute experimental pancreatitis in mice.

Authors:  A Demols; O Le Moine; F Desalle; E Quertinmont; J L Van Laethem; J Devière
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

Review 2.  Pancreatic cancer, inflammation, and microbiome.

Authors:  Constantinos P Zambirinis; Smruti Pushalkar; Deepak Saxena; George Miller
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.

Authors:  Timothy Chao; Emma E Furth; Robert H Vonderheide
Journal:  Cancer Immunol Res       Date:  2016-10-13       Impact factor: 11.151

4.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

5.  IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.

Authors:  Yuliya Pylayeva-Gupta; Shipra Das; Jesse S Handler; Cristina H Hajdu; Maryaline Coffre; Sergei B Koralov; Dafna Bar-Sagi
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

6.  Interleukin 17-producing γδT cells promote hepatic regeneration in mice.

Authors:  Raghavendra Rao; Christopher S Graffeo; Rishabh Gulati; Mohsin Jamal; Suchithra Narayan; Constantinos P Zambirinis; Rocky Barilla; Michael Deutsch; Stephanie H Greco; Atsuo Ochi; Lena Tomkötter; Reuven Blobstein; Antonina Avanzi; Daniel M Tippens; Yisroel Gelbstein; Eliza Van Heerden; George Miller
Journal:  Gastroenterology       Date:  2014-05-04       Impact factor: 22.682

Review 7.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

Review 8.  Inflammation and pancreatic cancer: an evidence-based review.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Curr Opin Pharmacol       Date:  2009-07-07       Impact factor: 5.547

9.  Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.

Authors:  Thomas R Flint; Tobias Janowitz; Claire M Connell; Edward W Roberts; Alice E Denton; Anthony P Coll; Duncan I Jodrell; Douglas T Fearon
Journal:  Cell Metab       Date:  2016-11-08       Impact factor: 27.287

10.  Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs.

Authors:  Geou-Yarh Liou; Heike Döppler; Brian Necela; Murli Krishna; Howard C Crawford; Massimo Raimondo; Peter Storz
Journal:  J Cell Biol       Date:  2013-08-05       Impact factor: 10.539

View more
  10 in total

Review 1.  Regulation and modulation of antitumor immunity in pancreatic cancer.

Authors:  Joshua Leinwand; George Miller
Journal:  Nat Immunol       Date:  2020-08-17       Impact factor: 25.606

2.  Effect of dexmedetomidine anesthesia on perioperative levels of TNF-α and IL-6 in patients with ovarian cancer.

Authors:  Maodong Liu; Yusheng Yi; Mingqiang Zhao
Journal:  Oncol Lett       Date:  2019-04-12       Impact factor: 2.967

Review 3.  Microbiome-Friend or Foe of Pancreatic Cancer?

Authors:  Jaroslaw Daniluk; Urszula Daniluk; Pawel Rogalski; Andrzej Dabrowski; Agnieszka Swidnicka-Siergiejko
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

Review 4.  The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention.

Authors:  Peter Gumberger; Bergthor Bjornsson; Per Sandström; Linda Bojmar; Constantinos P Zambirinis
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

5.  Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis.

Authors:  Ute Jungwirth; Antoinette van Weverwijk; Rachel J Evans; Liam Jenkins; David Vicente; John Alexander; Qiong Gao; Syed Haider; Marjan Iravani; Clare M Isacke
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

6.  Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults.

Authors:  Christiana Kartsonaki; Yuanjie Pang; Iona Millwood; Ling Yang; Yu Guo; Robin Walters; Jun Lv; Michael Hill; Canqing Yu; Yiping Chen; Xiaofang Chen; Eric O'Neill; Junshi Chen; Ruth C Travis; Robert Clarke; Liming Li; Zhengming Chen; Michael V Holmes
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

7.  MyD88 signalling is critical in the development of pancreatic cancer cachexia.

Authors:  Xinxia Zhu; Kevin G Burfeind; Katherine A Michaelis; Theodore P Braun; Brennan Olson; Katherine R Pelz; Terry K Morgan; Daniel L Marks
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-21       Impact factor: 12.910

8.  Blockade of Stromal Gas6 Alters Cancer Cell Plasticity, Activates NK Cells, and Inhibits Pancreatic Cancer Metastasis.

Authors:  Lucy Ireland; Teifion Luckett; Michael C Schmid; Ainhoa Mielgo
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

9.  TIPE2 Suppresses Malignancy of Pancreatic Cancer Through Inhibiting TGFβ1 Mediated Signaling Pathway.

Authors:  Fang Feng; Chunliang Liu; Huahui Bian; Wei Cai; Ying Zhou; Li Zhou; Zhixiang Zhuang
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

10.  Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma.

Authors:  Hweixian Leong Penny; Je Lin Sieow; Sin Yee Gun; Mai Chan Lau; Bernett Lee; Jasmine Tan; Cindy Phua; Florida Toh; Yvonne Nga; Wei Hseun Yeap; Baptiste Janela; Dilip Kumar; Hao Chen; Joe Yeong; Justin A Kenkel; Angela Pang; Diana Lim; Han Chong Toh; Tony Lim Kiat Hon; Christopher I Johnson; Hanif Javanmard Khameneh; Alessandra Mortellaro; Edgar G Engleman; Olaf Rotzschke; Florent Ginhoux; Jean-Pierre Abastado; Jinmiao Chen; Siew Cheng Wong
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.